RESCON SUMMIT highlights innovations in the respiratory sector and connected devices. At the event we will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses at on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices.
The IRDD Stream will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology.
Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.
The event highlights some of the innovators and innovations in the respiratory sector, addresses the importance of end users in the device development process, and presents recent advancements in improving patient adherence.
Some analysts predict that the global wearable injectors market will reach US$18.3 billion by 2028. This growth is being driven by the benefits these devices deliver to various stakeholders. For Pharma and Biotech companies, wearables offer the opportunity to grow market share and reduce competition.
Worldwide, patient and provider preferences are changing due to the covid-19 pandemic. The need to reduce patient exposure to the virus and free up healthcare resources is driving unprecedented change. IoT technology brings new opportunities and can help us establish a new normal with use cases and innovation for healthcare, COVID-19 testing, building health and remote device maintenance.
The conference represents a unique opportunity for learning, exchanging opinions, and expanding one’s network enabled by live presentations followed by dynamic Q&A sessions – providing the attendees with valuable insights from specialists in the sphere of Medical device
Manhattan, New York, USA